The initial reporter stated they received discrepant results for two patient samples tested with the elecsys vitamin d assay on a cobas e 411 immunoassay analyzer (serial number (b)(4)).The second sample also had a discrepant vitamin d result when tested on a cobas 8000 e 602 module.The first sample initially resulted in a vitamin d value of > 70.00 ng/ml when tested on the e411 analyzer.The sample was repeated in a second laboratory using an unknown chemiluminescence method, resulting in a value of 32.04 ng/ml.The 32.04 ng/ml value was believed to be correct.The sample was repeated on the customer's e411 analyzer on (b)(6) 2021, resulting in a value of 68.05 ng/ml.No incorrect results were reported outside of the laboratory for this sample.The second sample initially resulted in a vitamin d value of > 70 ng/ml when tested on the e411 analyzer on (b)(6) 2021.The sample was sent to another laboratory for testing on an architect analyzer, resulting in a value of 15.3 ng/ml on (b)(6) 2021.An aliquot of the sample was repeated on the e411 after re-centrifugation, resulting in a value of 67.5 ng/ml on (b)(6) 2021.The aliquot was also tested on an e 602 analyzer, resulting in a value of 160 nmol/l on (b)(6) 2021.It was asked, but unknown if any incorrect results were reported outside of the laboratory for this sample.
|
There were no alarms for the last calibration occurring on (b)(6) 2021.Quality controls were within range, showing no indication of a reagent or instrument performance issue.Upon review of the alarm trace, an insufficient sample volume alarm and a clot pipetting alarm occurred on the day of the event near the time the sample was processed.This is an indication of poor sample quality.The investigation could not identify a product problem.The cause of the event could not be determined.
|